Literature DB >> 34795154

NS5A-ISGylation via Lysine 26 Has a Critical Role for Efficient Propagation of Hepatitis C Virus Genotype 2a.

Rheza Gandi Bawono1, Takayuki Abe1, Yasuaki Shibata1, Chieko Matsui1, Lin Deng1, Ikuo Shoji1.   

Abstract

We previously reported that hepatitis C virus (HCV) NS5A (1b, Con1) protein accepts covalent ISG15 conjugation at specific lysine (Lys) residues (K44, K68, K166, K215 and K308), exhibiting proviral effects on HCV RNA replication. Here we investigated a role of NS5A-ISGylation via Lys residues in HCV propagation using HCV infectious clone. The alignment of amino acid sequences revealed that 5 Lys residues (K20, K26, K44, K139, and K166) of the 13 Lys residues within NS5A (genotype 2a, JFH1 strain) were conserved compared to those of HCV (genotype 1b, Con1 strain). The cell-based ISGylation assay revealed that the K26 residue in the amphipathic helix (AH) domain and the K139 residue in domain I of NS5A (2a, JFH1) had the potential to accept ISGylation. Use of the HCV replicon carrying luciferase gene revealed that the K26 residue but not K139 residue of NS5A (2a, JFH1) was important for HCV RNA replication. Furthermore, cell culture HCV revealed that the mutation with the K26 residue in combination with K139 or K166 on NS5A (2a, JFH1) resulted in complete abolishment of viral propagation, suggesting that the K26 residue collaborates with either the K139 residue or K166 residue for efficient HCV propagation. Taken together, these results suggest that HCV NS5A protein has the potential to accept ISGylation via specific Lys residues, involving efficient viral propagation in a genotype-specific manner.

Entities:  

Keywords:  Lys residue; hepatitis C virus; viral propagation

Mesh:

Substances:

Year:  2021        PMID: 34795154      PMCID: PMC8622218     

Source DB:  PubMed          Journal:  Kobe J Med Sci        ISSN: 0023-2513


  34 in total

Review 1.  Hepatitis C.

Authors:  Daniel P Webster; Paul Klenerman; Geoffrey M Dusheiko
Journal:  Lancet       Date:  2015-02-14       Impact factor: 79.321

2.  The interferon stimulated gene 15 functions as a proviral factor for the hepatitis C virus and as a regulator of the IFN response.

Authors:  Ruth Broering; Xiaozhen Zhang; Shyam Kottilil; Martin Trippler; Min Jiang; Mengji Lu; Guido Gerken; Joerg F Schlaak
Journal:  Gut       Date:  2010-08       Impact factor: 23.059

3.  Hepatitis C virus infection in phenotypically distinct Huh7 cell lines.

Authors:  Bruno Sainz; Naina Barretto; Susan L Uprichard
Journal:  PLoS One       Date:  2009-08-10       Impact factor: 3.240

4.  Complete replication of hepatitis C virus in cell culture.

Authors:  Brett D Lindenbach; Matthew J Evans; Andrew J Syder; Benno Wölk; Timothy L Tellinghuisen; Christopher C Liu; Toshiaki Maruyama; Richard O Hynes; Dennis R Burton; Jane A McKeating; Charles M Rice
Journal:  Science       Date:  2005-06-09       Impact factor: 47.728

5.  Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase.

Authors:  Timothy L Tellinghuisen; Joseph Marcotrigiano; Charles M Rice
Journal:  Nature       Date:  2005-05-19       Impact factor: 49.962

6.  Cyclophilin A interacts with domain II of hepatitis C virus NS5A and stimulates RNA binding in an isomerase-dependent manner.

Authors:  Toshana L Foster; Philippe Gallay; Nicola J Stonehouse; Mark Harris
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

Review 7.  Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review.

Authors:  Oluwaseun Falade-Nwulia; Catalina Suarez-Cuervo; David R Nelson; Michael W Fried; Jodi B Segal; Mark S Sulkowski
Journal:  Ann Intern Med       Date:  2017-03-21       Impact factor: 25.391

8.  ISGylation of Hepatitis C Virus NS5A Protein Promotes Viral RNA Replication via Recruitment of Cyclophilin A.

Authors:  Takayuki Abe; Nanae Minami; Rheza Gandi Bawono; Chieko Matsui; Lin Deng; Takasuke Fukuhara; Yoshiharu Matsuura; Ikuo Shoji
Journal:  J Virol       Date:  2020-09-29       Impact factor: 5.103

9.  Domain III of NS5A contributes to both RNA replication and assembly of hepatitis C virus particles.

Authors:  Mair Hughes; Stephen Griffin; Mark Harris
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

10.  Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect.

Authors:  Min Gao; Richard E Nettles; Makonen Belema; Lawrence B Snyder; Van N Nguyen; Robert A Fridell; Michael H Serrano-Wu; David R Langley; Jin-Hua Sun; Donald R O'Boyle; Julie A Lemm; Chunfu Wang; Jay O Knipe; Caly Chien; Richard J Colonno; Dennis M Grasela; Nicholas A Meanwell; Lawrence G Hamann
Journal:  Nature       Date:  2010-04-21       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.